Regional evidence
Compare global genomic interpretation with evidence relevant to Arab and Gulf populations. Where the two disagree, VariantPulse surfaces the disagreement rather than picking a winner.
Global
ClinVar submissions, reference population frequencies and published international evidence. The reference cohorts behind these datasets are predominantly of European ancestry.
15 variants read from ClinVar
Regional
Observations from Arab and Gulf cohorts, where founder effects and higher consanguinity can make a variant behave differently from the global reference set.
7 variants held · Arab and Gulf population evidence
Of 7 variants held in both sources, 2 read differently and need a clinician to weigh them; 5 fall in the same clinical band, across 15 regional observations.
Frequencies are real gnomAD v4 Middle Eastern figures. Regional assertions are modelled for this workspace. Cited literature is real and is provided as supporting context. VariantPulse does not imply endorsement by, or integration with, any national programme or registry.
Human review required. VariantPulse does not rank one source above the other.
Global · ClinVar
Uncertain significancereviewed by expert panel · Last evaluated 30 Apr 2026
Regional · Regional Evidence Index
Pathogenic0 observations in 2,884 · updated 12 May 2026
Human review required
VUS globally, Pathogenic regionally. A clinician weighs both; neither source is treated as correct.
Global
Read from ClinVar, which aggregates submissions dominated by European-ancestry cohorts.
Regional
Modelled regional aggregation maintained inside this workspace.
VariantPulse analysis
One source places this variant in the clinically actionable band and the other does not. Global submitters downgraded this change to uncertain significance in April 2026. The regional index still carries the earlier pathogenic reading from haemoglobinopathy work-ups. Beta-thalassaemia carrier status is common in the UAE and drives premarital and reproductive counselling, so a disagreement here has direct family-planning consequences and must be resolved by a clinician, not by the software.
VariantPulse recommends manual review due to conflicting interpretation across evidence sources. It does not rank one source above the other.
Global · ClinVar
Uncertain significancereviewed by expert panel · Last evaluated 3 Mar 2017
Regional · Regional Evidence Index
Likely benign4 observations in 3,030 · updated 2 Mar 2026
Human review required
VUS globally, Likely benign regionally. A clinician weighs both; neither source is treated as correct.
Global
Read from ClinVar, which aggregates submissions dominated by European-ancestry cohorts.
Regional
Modelled regional aggregation maintained inside this workspace.
VariantPulse analysis
The sources place this variant in different bands without crossing the actionable boundary. In gnomAD v4 this change is about four times more frequent in the Middle Eastern reference group than globally. Higher-than-expected population frequency is a recognised line of evidence toward a benign reading, but the Middle Eastern group is only about 3,000 people, so the signal is flagged for review rather than applied automatically.
VariantPulse recommends manual review due to conflicting interpretation across evidence sources. It does not rank one source above the other.
Variants where the regional index agrees with the global consensus.
| Variant | Global | Regional | Observations | Cohort |
|---|---|---|---|---|
| BRCA1c.5056C>T | Likely pathogenic | Likely pathogenic | 0 | 3,042 |
| LDLRc.1381G>T | Likely pathogenic | Likely pathogenic | 0 | 3,042 |
| HBBc.364G>C | Pathogenic | Pathogenic | 11 | 3,031 |
| MYBPC3c.776delinsTT | Likely pathogenic | Likely pathogenic | 0 | 3,042 |
| BRCA1c.1140dup | Pathogenic | Pathogenic | 0 | 3,042 |
A variant that is common and harmless in one population can be a founder variant in another. When the reference data behind a classification does not include the population a patient belongs to, a confident global reading can still be the wrong reading locally. VariantPulse holds both and asks a clinician to weigh them, rather than resolving the disagreement automatically.